Photodynamic therapy: current status and future directions.
about
New "light" for one-world approach toward safe and effective control of animal diseases and insect vectors from leishmaniac perspectivesModulation of the Anti-Tumor Efficacy of Photodynamic Therapy by Nitric OxideTargeting mitochondria by Zn(II)N-alkylpyridylporphyrins: the impact of compound sub-mitochondrial partition on cell respiration and overall photodynamic efficacyDirect 1O2 optical excitation: A tool for redox biology.O2 and Ca(2+) fluxes as indicators of apoptosis induced by rose bengal-mediated photodynamic therapy in human oral squamous carcinoma cells.Comparative Study on the Efficiency of the Photodynamic Inactivation of Candida albicans Using CdTe Quantum Dots, Zn(II) Porphyrin and Their Conjugates as Photosensitizers.Efficacy of Rhodamine Light in the Treatment of Superficial Vascular Lesions of the FaceTMPyP4 promotes cancer cell migration at low doses, but induces cell death at high dosesLowering photosensitizer doses and increasing fluences induce apoptosis in tumor bearing miceOncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.Photodynamic therapy (PDT) of cancer: from local to systemic treatment.Photosensitizers binding to nucleic acids as anticancer agents.Cell Death Mechanisms in Tumoral and Non-Tumoral Human Cell Lines Triggered by Photodynamic Treatments: Apoptosis, Necrosis and Parthanatos.Mechanisms of Vesicular Stomatitis Virus Inactivation by Protoporphyrin IX, Zinc-Protoporphyrin IX, and Mesoporphyrin IX.Photoinduced effects of m-tetrahydroxyphenylchlorin loaded lipid nanoemulsions on multicellular tumor spheroids.Cationic amphiphilic Zn-porphyrin with high antifungal photodynamic potency.Important cellular targets for antimicrobial photodynamic therapy.Bystander effects of nitric oxide in anti-tumor photodynamic therapy.Post-illumination cellular effects of photodynamic treatment.Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors.Synthesis, characterization and in vitro and in vivo photodynamic activities of a gallium(iii) tris(ethoxycarbonyl)corrole.Photosensitizer (PS)/polyhedral oligomeric silsesquioxane (POSS)-crosslinked nanohybrids for enhanced imaging-guided photodynamic cancer therapy.Antagonistic effects of nitric oxide in a glioblastoma photodynamic therapy model:mitigation by BET bromodomain inhibitor JQ1.Role of Endogenous Nitric Oxide in Hyperaggressiveness of Tumor Cells that Survive a Photodynamic Therapy Challenge.Imaging-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model.Effect of multiple cyclic RGD peptides on tumor accumulation and intratumoral distribution of IRDye 700DX-conjugated polymers.An updated overview on the development of new photosensitizers for anticancer photodynamic therapy.Evaluating Nanoshells and a Potent Biladiene Photosensitizer for Dual Photothermal and Photodynamic Therapy of Triple Negative Breast Cancer CellsPhotodynamic Therapy for Metastatic Melanoma Treatment: A ReviewCombination of Photodynamic Therapy with Radiotherapy for Cancer Treatment
P2860
Q26700044-69BF19F3-E152-4D65-812F-A83CA66A01E8Q28079319-34DC6112-842C-400B-9286-5E0400A3E615Q28543186-AD26E7DC-96BB-4ACA-8C2D-5A4656CB1D73Q33746305-C68C3B5F-C315-47B9-8082-7ABCF1FC9EC6Q35625066-6BB9C93C-D2FF-4311-A04E-EECAFBD116F1Q35636837-33221AFE-4786-4A71-A4E7-0E424D3E3395Q36025936-F64A3BEF-95B6-4A7E-AB23-E22E0BC58624Q36933901-C4A5CE1C-E429-406D-A894-7025432DA9AFQ37103182-6E20D4D9-3167-4205-B758-90BD4E11E071Q37676077-CA95AE85-C594-4ACA-B2D6-5C123AAC9AC7Q38556357-273CF432-E3AB-4683-AF7B-AE470C6B3E04Q38710646-D32890AD-4F39-4A31-8700-811A12C8F99CQ38720024-F28FA234-38D1-449D-B901-6CF24E10A131Q40271348-7E61F4F9-F88C-4635-ABCC-00E8CA1A58F9Q41040026-8580FCA9-C73A-4A81-B376-9770711813FCQ46282065-7180B508-BA65-44DB-8CB4-15B295FFB7EBQ46542989-A5FE5076-E3EC-4C72-B716-2F0326929E1CQ47094628-B84C5872-8439-4F11-A4E5-024307BADFEFQ47141289-AC005E6C-A780-40AC-ADE1-5EA2A7461AB3Q47910582-C9EC468D-66BE-40BA-B006-8CF32005CFA6Q47930541-6AAF1793-813E-4533-83F5-4BBFAF880BDCQ47949536-DE53D241-4841-4B35-857A-D542495B9370Q50027143-8B526F07-D5E5-4162-A5C0-F03E824653E1Q50069687-A7046E6D-CD9A-44D1-8CF5-B703ED2FC1F9Q50113746-39625680-6304-433D-B3C8-F3BB8CB1D21CQ55130405-52A57A2F-84EE-489C-B5A9-BB7174C18A5CQ55285087-5C9BE585-966E-4701-975A-98F716D8AC35Q58702509-9DC19F26-2392-4A57-8224-3323DDAF94A3Q58786646-F82EE1A4-4E4E-4089-B075-E593F0AC6A8EQ59128768-E41FD324-1D83-42AC-B375-EEF54D74F5BE
P2860
Photodynamic therapy: current status and future directions.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Photodynamic therapy: current status and future directions.
@en
type
label
Photodynamic therapy: current status and future directions.
@en
prefLabel
Photodynamic therapy: current status and future directions.
@en
P356
P1476
Photodynamic therapy: current status and future directions
@en
P2093
Ludmil Benov
P356
10.1159/000362416
P478
24 Suppl 1
P577
2014-05-10T00:00:00Z